FINWIRES · TerminalLIVE
FINWIRES

Boston Scientific Cuts Outlook Amid Weak Demand for Watchman Heart Device

By
Boston Scientific Cuts Outlook Amid Weak Demand for Watchman Heart Device

Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, citing factors including weak demand for its Watchman heart implant.

The medical device maker now expects 2026 adjusted earnings per share of $3.28 to $3.32, down from its previous outlook of $3.34 to $3.41. The FactSet-polled consensus is for $3.36.

Full-year net sales are now projected to grow 5.5% to 6.5% from last year, compared with its prior growth estimate of 7% to 8.5% growth. Analysts in a FactSet survey are projecting sales of $21.59 billion, indicating a 7.6% year-over-year growth.

"Our guidance reduction is concentrated in two areas. First, Watchman, where the US market has slowed sharply and unexpectedly, primarily driven by compounding clinical evidence, which has impacted referral patterns," Chief Executive Mike Mahoney said during an earnings call, according to a FactSet transcript. "And second, (electrophysiology), where we did not anticipate the degree of competitive share movement we're now seeing in the US market."

Watchman underperformed expectations in the second quarter, with US sales growing 3% organically, according to a slide deck. Electrophysiology revenue rose 9.1% globally, but was weighed down by competitive pressures in the US.

Mahoney flagged a downbeat demand outlook for Watchman for 2026, with global sales likely to be flat to up low single digits.

"We anticipate that year-over-year concomitant (procedure) growth will materially slow in the second half due to higher comps from 2025," Mahoney said. "Our outlook does not anticipate any improvement in standalone procedural growth trends in the second half."

Boston Scientific expects flat second-half global growth for electrophysiology in the US, Mahoney told analysts.

Johnson & Johnson (JNJ) raised its full-year outlook earlier this month as its innovative medicine and medical device businesses drove a strong second quarter.

For the third quarter, Boston Scientific projects adjusted EPS of $0.80 to $0.82 and net sales growth of 3% to 5%. Analysts are looking for $0.84 and $5.38 billion, respectively.

The company reported June-quarter adjusted EPS of $0.86, up from $0.75 a year earlier and surpassing Wall Street's $0.83 estimate. Net sales grew 7.5% to $5.44 billion, while analysts expected $5.36 billion.

Sales in the cardiovascular business increased 8.3% year over year to $3.62 billion. The MedSurg division delivered a 5.9% jump to $1.82 billion, led by a double-digit gain in neuromodulation.

Boston Scientific's shares rose 0.7% intraday Wednesday, reversing course from earlier in the day. The stock has plunged 51% so far this year.

Price: $46.43, Change: $+0.37, Percent Change: +0.80%

Related Articles

Australia's Headline Inflation Eases in June, Supporting Case for Interest Rate Hold
US Markets

Australia's Headline Inflation Eases in June, Supporting Case for Interest Rate Hold

Australia's annual pace of inflation eased more than expected in June, potentially cooling near-term expectations for an interest rate hike, even as rising housing costs continued to weigh on the reading.The country's consumer price index rose 3.8% in the 12 months to June, down from a 4% rate logged in May, data from the Australian Bureau of Statistics showed on Wednesday.The closely watched annual trimmed mean inflation, which removes outliers on the low and high end of price movements, was unchanged from the previous month at 3.6% in June.Westpac expected a June CPI of 4.2% and a trimmed mean inflation reading of 3.7%. BofA Securities, which forecast headline CPI at 3.9%, recently said any downside surprises to its estimate should support the case for Australia's central bank to keep borrowing costs unchanged at an upcoming policy meeting in August.Housing was the largest contributor to annual inflation in June with a rise of 6.8%, reflecting elevated electricity costs that are over 22% higher than they were a year earlier following the end of government rebate programs."Annual inflation for new dwellings has reached its highest level in almost three years, at 5.8%," said Rachael McCririck, head of price statistics at the ABS. "This was driven by builders passing on higher material and labor costs."The data also showed a moderation in annual inflation for transport to an increase of just 0.1% in June from a 3.3% rise in May as automotive fuel prices declined for three straight months.

ASX 200
SK Hynix's Second-Quarter Profit Soars 13-Fold as Revenue Jumps 257% on AI Memory Boom
US Markets

SK Hynix's Second-Quarter Profit Soars 13-Fold as Revenue Jumps 257% on AI Memory Boom

SK Hynix (KRX:000660) reported a 1,241% year-over-year jump in attributable net profit for the second quarter, which it attributed to strong demand for high-value memory products amid strong AI demand.Attributable net profit surged 13-fold to 93.82 trillion won from 6.997 trillion won a year earlier, according to a Korea bourse filing early Wednesday.Net profit margin during the first half reached 118%.The South Korean memory chipmaker posted a 257% year-over-year jump in revenue to 79.3 trillion won from 22.2 trillion won, marking an all-time quarterly high for the company and pushing cumulative first-half revenue above 100 trillion won for the first time in its history, according to a press release.Cumulative revenue totaled 131.9 trillion won in the first half, up 231% from 39.9 trillion won a year prior."Driven by sustained demand growth from expanding AI infrastructure investments, high-performance products for AI servers led price increases, enabling the company to surpass its previous record set in the prior quarter," SK hynix said.The company expects the momentum in memory demand to persist as major tech companies ramp up their AI infrastructure spending, raising demand for its products.SK hynix supplies advanced memory chips to major global tech companies including Nvidia, Microsoft, Apple and Amazon Web Services, among others.The company said it began mass shipments of its new HBM4 product in the second quarter and will ramp up production in the second half of the year.SK Hynix added that it has finalized long-term agreements with around 10 customers, including key strategic partners, and is continuing further talks with major industry clients.In recent days, the company struck major investment deals to support the AI boom, including a memorandum of understanding with Nvidia last week to co-develop next-generation AI memory.The long-term partnership, amounting to $500 billion, was announced during South Korean President Lee Jae Myung's visit to San Francisco.Also last week, the company disclosed plans to build P&T7, its next-generation advanced packaging and testing facility, in South Korea's Cheongju, with a total investment of 7.09 trillion won.

KRX:000660
Hindustan Unilever's Fiscal First-Quarter Net Profit Down 3%; Revenue Jumps 10%
US Markets

Hindustan Unilever's Fiscal First-Quarter Net Profit Down 3%; Revenue Jumps 10%

Hindustan Unilever (BOM:500696, NSE:HINDUNILVR) reported a 3% year-over-year drop in attributable net profit in the fiscal first quarter ended June 30, despite posting higher revenue.Attributable net profit slipped to 26.7 billion rupees from 27.6 billion rupees a year earlier, according to an Indian bourse filing on Tuesday.Earnings per share fell to 11.38 yuan from 11.62 yuan.Net profit was weighed down by a one-off tax credit of 3.3 billion rupees in the year-ago period.The Indian consumer goods maker posted a 10.4% year-over-year jump in revenue to 171.5 billion rupees from 155.5 billion rupees.During the company's earnings call, CEO and Managing Director Priya Nair told analysts that the revenue growth of 10% was driven equally by volume and price."This represents our highest growth in 13 quarters. It reflects the result of decisive actions taken to transform our portfolio, sharpen execution, and strengthen market development," Nair said, according to a transcript of the call published by Investing.com.CFO Niranjan Gupta attributed the revenue jump to the 5% increase in underlying volume growth across product lines."Fabric wash delivered a broad-based double-digit volume-led growth. Bars and powders sustained their step-up, while liquids grew competitively and accelerated its double-digit growth trajectory," said Gupta.By segment, Home Care delivered a 14% jump in underlying sales, the fastest in three years, while underlying sales growth across the Beauty & Wellbeing, Personal Care, and Foods segments rose 12%, 4% and 7%, respectively.Looking ahead, Gupta said the company expects fiscal 2026-2027 to be "better" than fiscal 2025-2026."While commodities and currencies remain elevated, our approach remains consistent and disciplined, driving structural savings, taking calibrated pricing actions, and making judicious media investments," Gupta added.

BOM:500696NSE:HINDUNILVR